Cargando…
Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
BACKGROUND: The variable course of autosomal dominant polycystic kidney disease (ADPKD), and the advent of renoprotective treatment require early risk stratification. We applied urinary metabolomics to explore differences associated with estimated glomerular filtration rate (eGFR; CKD-EPI equation)...
Autores principales: | Dekker, Shosha E. I., Verhoeven, Aswin, Soonawala, Darius, Peters, Dorien J. M., de Fijter, Johan W., Mayboroda, Oleg A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244119/ https://www.ncbi.nlm.nih.gov/pubmed/32442208 http://dx.doi.org/10.1371/journal.pone.0233213 |
Ejemplares similares
-
Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients
por: Dekker, Shosha E.I., et al.
Publicado: (2022) -
The impact of pre-transplantation nephrectomy on quality of life in patients with autosomal dominant polycystic kidney disease
por: Geertsema, Paul, et al.
Publicado: (2023) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022) -
Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
por: Messchendorp, A. Lianne, et al.
Publicado: (2017) -
Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study
por: Lantinga, Marten A., et al.
Publicado: (2016)